戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 o bedtime), and evening (four hours prior to bedtime).
2  mg (P <0.01 vs. omeprazole twice daily plus bedtime).
3 ing the first non-REM sleep period at normal bedtime.
4  medication should not be routinely dosed at bedtime.
5 to sleep, occurring approximately 2 h before bedtime.
6 east a few nights per week within 1 h before bedtime.
7 h reading a printed book in the hours before bedtime.
8 zepam or high-dose melatonin taken orally at bedtime.
9  no treatment administered 30 minutes before bedtime.
10 te-release niacin (</= 150 mg) as placebo at bedtime.
11 tivity, and delirium during the hours before bedtime.
12 mg [n=106]) or placebo (n=103) 30 min before bedtime.
13 larly that administered in the evening or at bedtime.
14 e light intensity was the same as before the bedtime.
15  with omeprazole twice daily with placebo at bedtime.
16 28 ppm) NaF or the two-solution rinse before bedtime.
17  with those who maintained regular nocturnal bedtimes.
18 alternative regimens of melatonin (5.0 mg at bedtime, 0.5 mg at bedtime, and 0.5 mg taken on a shifti
19 00 mg BMS-663068 plus 100 mg ritonavir every bedtime, 1200 mg BMS-663068 plus 100 mg ritonavir Q12H,
20 nitiated therapy with thalidomide, 200 mg at bedtime (18 patients), or 300 mg at bedtime (4 patients)
21 reported sleep duration was 07:07 +/- 01:31 (bedtime 22:32 +/- 01:27, wake up time: 06:17 +/- 01:25 h
22 hospitalization and ED visits, which favored bedtime (22.6 vs 30.0 events per 100 patient-years; aHR,
23  coronary artery disease) were randomized to bedtime (394 participants) vs usual care (382 participan
24 00 mg at bedtime (18 patients), or 300 mg at bedtime (4 patients).
25 bjects had acid breakthrough with placebo at bedtime; 7 with omeprazole at bedtime (P = NS); 4 with r
26                                              Bedtime access to and use of a media device were signifi
27  had been administered to their child before bedtime) according to a partially double-blind randomiza
28  dose consumed in the morning (12 h prior to bedtime), afternoon (eight hours prior to bedtime), and
29                        CAI administration at bedtime ameliorated gastrointestinal complaints in many
30  The delay region started a few hours before bedtime and extended through the night.
31 eep bout, number of naps, and variability in bedtime and sleep duration-were derived from 7-day accel
32 rs differences in recorded vs. self-reported bedtime and sleep duration.
33 ght during the daytime and more light in pre-bedtime and sleep episodes than recommended [T.
34  grade average associates with later weekend bedtime and smaller grey matter volumes in medial brain
35  finger-tapping motor sequence task (MST) at bedtime and tested the following morning.
36 olume correlates inversely with both weekend bedtime and wake up time, and also with poor school perf
37 ns probing visual perception of light in the bedtime and waking environments were added to the Consen
38 In addition, subjective light information at bedtime and waking was related to both objective and sub
39   Daily screen use was associated with later bedtimes and approximately 50 minutes less sleep each we
40 Practitioners should encourage regularity in bedtimes and rise times as a first step in treatment, an
41 nsomnia, the authors found that regularizing bedtimes and rise times was often sufficient to bring ab
42 men maintain nearly identical and consistent bedtimes and wake times.
43 disparities across mean levels (duration and bedtime) and variability of sleep (duration, bedtime, ri
44 to bedtime), afternoon (eight hours prior to bedtime), and evening (four hours prior to bedtime).
45 s of melatonin (5.0 mg at bedtime, 0.5 mg at bedtime, and 0.5 mg taken on a shifting schedule) for je
46 in our study were posture, smartphone use at bedtime, and duration of device use, watching movies, so
47 nts is required to minimize device access at bedtime, and future research is needed to evaluate the i
48  trough of mean IOP occurred just before the bedtime, and then IOP gradually increased and peaked at
49 nd lower likelihoods of flourishing, regular bedtimes, and moderate screen time among Asian American
50      Mean differences for sleep duration and bedtimes, and prevalence ratios for sleep quality were c
51 dtime (P = NS); 4 with ranitidine, 150 mg at bedtime; and 3 with ranitidine, 300 mg at bedtime (P < 0
52 ne, waking (AOR = 2.6, 95% CI: 1.4, 5.1) and bedtime (AOR = 2.3, 95% CI: 1.2, 4.6).
53  95% confidence interval (CI): 1.8, 7.9) and bedtime (AOR = 2.5, 95% CI: 1.3, 4.9); dopamine, waking
54 y activity and of light exposure, with later bedtimes ( approximately 1 h) associated with more eveni
55 ith type 1 DM, physiologic replacement, with bedtime basal insulin and a mealtime rapid-acting insuli
56 ujube leaf infusion as a healthy antioxidant bedtime beverage, and associate it to an unreported anti
57 ba Mill., jujube, leaf infusions are popular bedtime beverages as they improve sleep by soothing the
58 time box instead (eg, reading, puzzles); (2) bedtime box (BB only): used matched before-bed activitie
59 e hour before bed and used activities from a bedtime box instead (eg, reading, puzzles); (2) bedtime
60                               Parentally set bedtimes can be effective in increasing the sleep durati
61 leep restriction to 5 h with fixed nocturnal bedtimes (circadian alignment) or with bedtimes delayed
62  who were receiving clozapine monotherapy at bedtime completed the MATRICS Consensus Cognitive Batter
63 s from meals and snacks consumed during each bedtime condition.
64 by 122 +/- 25 min per night during the 5.5-h bedtime condition.
65 ons were related to actual light measures at bedtime, controlling for shift type and experimental con
66                                              Bedtime cortisol levels did not differ significantly bet
67 urnal bedtimes (circadian alignment) or with bedtimes delayed by 8.5 h on 4 of the 8 days (circadian
68 eep in cirrhosis was associated with delayed bedtime, delayed wake-up time, and evening chronotypolog
69 carbidopa-levodopa apart from a single daily bedtime dose, Rytary (Amneal Pharmaceuticals), additiona
70 cid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose.
71                                Mean achieved bedtime doses were 15.6 mg of prazosin (SD=6.0) and 18.8
72 rovided urine samples for 3 days (waking and bedtime) during midpregnancy.
73 ed at wakeup, 30 min after awakening, and at bedtime each day.
74 ation timing, switching antihypertensives to bedtime failed to reduce a composite of death or major c
75 0 mg alpelisib (n = 5) or placebo (n = 6) at bedtime, followed by measurement of glucose, insulin, an
76 ventions involved 3 inpatient days with 10-h bedtimes, followed by 8 inpatient days of sleep restrict
77 ents) or placebo (56 patients) once daily at bedtime for 12 weeks in a double-blind study.
78  GHRH (1 mg/d), or placebo 30 minutes before bedtime for 20 weeks.
79 24 h at a fixed clock time 1 h before target bedtime for 26 weeks.
80 collected salivary cortisol at awakening and bedtime for 3 days, and gave a blood sample which was an
81 ary cortisol samples collected at waking and bedtime for children on 3 separate days.
82 maximum dose of 5 mg midmorning and 20 mg at bedtime for men and 2 mg midmorning and 10 mg at bedtime
83 h acetazolamide or placebo, taken 1 h before bedtime for six nights with 2 wk of washout.
84 or 274 mg of ADS-5102 administered orally at bedtime for up to 25 weeks.
85 ime for men and 2 mg midmorning and 10 mg at bedtime for women.
86 acebo daily, one hour before their preferred bedtime, for three to nine weeks.
87 lutide 1.5 mg, dulaglutide 0.75 mg, or daily bedtime glargine.
88 r, consuming theacrine within eight hours of bedtime improved next-morning cognitive performance, wit
89 3819 patients) once daily between dinner and bedtime in a double-blind, treat-to-target, event-driven
90             Montelukast, 10 mg once daily at bedtime; inhaled beclomethasone, 200 microg twice daily,
91 ived inhaled insulin before each meal plus a bedtime injection of ultralente insulin, performed home
92 ial Technosphere inhaled insulin powder plus bedtime insulin glargine; or twice daily premixed biaspa
93                 This article discusses using bedtime insulin with oral agents, basal-prandial insulin
94 daily antihypertensive medications either at bedtime (intervention) or per usual care control (largel
95 nal conclusions of meaningful effects of the Bedtime Learning Together (BLT) math app on children's m
96 at promoting MVPA may help to elicit earlier bedtimes, lengthen sleep duration, and increase sleep ef
97  daily output, and the ratio of awakening to bedtime levels.
98                                   Higher pre-bedtime light exposure was associated with longer sleep
99 A single dose (1.76 +/- 0.41 g/kg) of UCS at bedtime maintains plasma glucose concentrations > or = 3
100                   Problematic use of PMDs at bedtime may be considered an unsafe act for healthcare w
101             Interventions focused on earlier bedtimes may offer a simple, pragmatic, effective way to
102                          ADS-5102, 274 mg at bedtime, may be an effective treatment for LID.
103  a strong and consistent association between bedtime media device use and inadequate sleep quantity (
104 signed to daily treatment with bright light, bedtime melatonin, both or placebos only in a 3.5-year d
105           In patients with type 2 DM, adding bedtime neutral protamine Hagedorn (isophane) insulin to
106 rtile range increase in mean log cortisol at bedtime (odds ratio, 2.2; 95% confidence interval, 1.09-
107    Bedtime ranitidine is more effective than bedtime omeprazole on residual nocturnal acid secretion
108 muscarinic agents administered orally before bedtime on 1 night greatly reduced OSA severity.
109 ional, and physical states were completed at bedtime on each of three consecutive days.
110 bedtime with that of a dose of ranitidine at bedtime on residual nocturnal acid secretion in patients
111 ter-generation Asian American), have regular bedtimes (OR, 0.80 [95% CI, 0.69-0.92] for second-genera
112 ticipated each in four experiments involving bedtime oral administration of placebo, 2.5, 3.0, and 3.
113 h later (sleep restriction) than their usual bedtime, over 2 intervention weeks separated by a 1-wk w
114 at bedtime; and 3 with ranitidine, 300 mg at bedtime (P < 0.05, ranitidine vs. placebo).
115 ith placebo at bedtime; 7 with omeprazole at bedtime (P = NS); 4 with ranitidine, 150 mg at bedtime;
116                                     Prior to bedtime, participants utilized nine popular sleep device
117 nsion treatment time (on awakening versus at bedtime; per 1-SD elevation: hazard ratio, 1.44; 95% con
118 90 +/- 369 kcal/d during the 5.5-h and 8.5-h bedtime periods, respectively; P = 0.58), and we found n
119 llowed by different treatment supplements at bedtime: placebo; additional omeprazole, 20 mg; ranitidi
120 ith thalidomide 100 to 200 mg orally (PO) at bedtime (qhs) with serial increments of 50 to 100 mg at
121 .023) and negatively correlated with in vivo bedtime (r = -0.54; P = 0.020).
122                                              Bedtime ranitidine is more effective than bedtime omepra
123                     Additional omeprazole at bedtime reduced the percentage of time with intragastric
124                                Ranitidine at bedtime reduced this parameter more, 5% with 150 mg and
125                                    Recurrent bedtime restriction can modify the amount, composition,
126 bedtime) and variability of sleep (duration, bedtime, risetime, and efficiency) than other groups.
127 bility across multiple dimensions (duration, bedtime, risetime, efficiency, and latency) over 3 weeks
128 ity, separation anxiety, nighttime fears and bedtime rituals, cognitive deficits, oppositional behavi
129                          Mothers reported on bedtime routine and sleep behaviors, infant sleep durati
130                                 A consistent bedtime routine, falling asleep alone, and other sleep p
131  with suspected CS with 24-h urine cortisol, bedtime salivary cortisol and/or 1 mg dexamethasone supp
132            Prazosin (mean dose=9.5 mg/day at bedtime, SD=0.5) was superior to placebo for the three p
133  Non-White race, low household income, later bedtime, short sleep duration, variable sleep timing, lo
134 istent relationship between consumption of a bedtime snack and improved glycemic control, especially
135 ion studies to determine whether consuming a bedtime snack improves fasting hyperglycemia and/or over
136                  Current advice to consume a bedtime snack is based on a limited number of interventi
137                                  Consuming a bedtime snack is often recommended for people with type
138 a no-snack control, nor have used a feasible bedtime snack option that could be translated into every
139 diabetes that included the intervention of a bedtime snack, consumed >30 min after dinner and <2 h be
140 their discoveries to how children understand bedtime stories.
141 ddlers (n = 80) during the presentation of a bedtime story during natural sleep.
142  received preprandial inhaled insulin plus a bedtime subcutaneous ultralente insulin injection.
143 a maintaining shorter sleep phases and later bedtimes, synchronized with sunrise.
144 leep health habits, and minimizing excessive bedtime technology.
145 n exhibited shorter sleep duration and later bedtime than White children.
146      Twice daily (after breakfast and before bedtime), the subjects received a one-minute rinse with
147 point of a student's nightly sleep window or bedtime timing variability.
148 ng session that was intended to extend their bedtime to 8.5 hours (sleep extension group) or to conti
149 stationary video cameras from 2 hours before bedtime until the first time the youth attempted sleep (
150                                              Bedtime use of insulin glargine results in fewer episode
151 ne and smartwatch in bed, using light before bedtime, using light in the morning and during daytime).
152   Importantly, compared with White children, bedtime variability was greater among Asian (beta = 0.04
153 re was no difference in primary outcomes for bedtime vs usual care in a modified intention-to-treat a
154 bank cohort, 10 interpretable sleep measures-bedtime, wake-up time, sleep duration, wake after sleep
155 dations, removing screen time before toddler bedtime was feasible and showed modest preliminary benef
156          Interventions that included earlier bedtimes were associated with a 47-minute sleep extensio
157                                              Bedtimes were manipulated to be 1 hour later (sleep rest
158  the effect of a third dose of omeprazole at bedtime with that of a dose of ranitidine at bedtime on

 
Page Top